Cronos Group Inc. Announces Results of 2025 Annual Meeting of Shareholders

June 23, 2025 at 17:30 PM EDT

TORONTO, June 23, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) today announced that at its Annual Meeting of Shareholders held on Friday, June 20, 2025 (the “Meeting”), shareholders holding a total of 276,989,452 common shares of the Company voted in person or by proxy, representing 71.87% of the total number of common shares of the Company outstanding.

Each of the directors listed as a nominee in the Company’s definitive proxy statement dated April 25, 2025 was elected as a director of the Company, with each director receiving in excess of 92.3% of the votes cast in favor of his or her election. The detailed results of the vote for the election of directors are as follows:

Name of Director	Number of Shares Voted For	Percentage of Shares Voted For	Number of Shares Withheld from Voting	Percentage of Shares Withheld from Voting
Michael Gorenstein	206,219,875	92.38%	17,012,443	7.62%
Jason Adler	215,665,946	96.61%	7,566,372	3.39%
Murray Garnick	215,548,312	96.56%	7,684,006	3.44%
Kamran Khan	216,349,694	96.92%	6,882,624	3.08%
Dominik Meier	216,404,347	96.94%	6,827,971	3.06%
Elizabeth Seegar	211,177,232	94.60%	12,055,086	5.40%
James Rudyk	215,956,203	96.74%	7,276,115	3.26%

Shareholders also approved an advisory (non-binding) resolution on the compensation of the Company’s named executive officers, with 94.13% of votes cast in favor of such resolution, and approved the appointment of Davidson & Company LLP as the Company’s independent auditor for fiscal year 2025 and authorized the Board of Directors of the Company to fix the independent auditor's remuneration.

For complete results on all matters voted on at the Meeting, please see the Report of Voting Results filed on the Company’s SEDAR+ profile at www.sedarplus.com and the Company’s Form 8-K filed on EDGAR at www.sec.gov/edgar.

About Cronos

Cronos is an innovative global cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology and product development. With a passion to responsibly elevate the consumer experience, Cronos is building an iconic brand portfolio. Cronos’ diverse international brand portfolio includes Spinach®, PEACE NATURALS® and Lord Jones®. For more information about Cronos and its brands, please visit: thecronosgroup.com.

For further information, please contact:
Harrison Aaron
Investor Relations
Tel: (416) 504-0004
investor.relations@thecronosgroup.com

About Us

Additional Information

Website & Technical Help

Cronos Group Inc. Announces Results of 2025 Annual Meeting of Shareholders

More News